The research team analyzed existing study data on 948 patients who had presented to the ED following an MVC. At 6-week follow-up, they found no difference in risk for moderate to severe musculoskeletal pain between patients who were discharged with opioid analgesics or NSAIDS. However, the research team notes that at 6 weeks, patients who were prescribed opioids were more likely than those prescribed NSAIDS to report continued use of prescription opioid medications. Learn more...